Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 068H21A | IM |
dermatagraphia; hives; This spontaneous case was reported by a consumer and describes the occurrence of MECHANICAL URTICARIA (dermatagraphia) and URTICARIA (hives) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In December 2021, the patient experienced MECHANICAL URTICARIA (dermatagraphia) and URTICARIA (hives). In March 2022, MECHANICAL URTICARIA (dermatagraphia) and URTICARIA (hives) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. No concomitant medication was reported. It was reported that patient had roughly 3 months of hives and dermatagraphia post administration. It was unknown if the patient experienced any additional symptoms/events. No treatment information was reported.